Your session is about to expire
← Back to Search
Study Summary
This trial is testing a new drug, IMM-BCP-01, to see if it is safe and effective in treating people with mild to moderate COVID-19. The study will last 28 days, and will measure safety, tolerability, and viral clearance.
- COVID-19
- Coronavirus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this research include participants who are older than 35 years of age?
"This trial is specifically searching for patients aged 18 to 50 years. In contrast, there are 140 studies targeting minors and 911 trials recruiting persons over 65."
Could you please explain the safety profile of IMM-BCP-01 for human subjects?
"According to our internal assessment, IMM-BCP-01's safety is tentatively rated a 1 as this trial has only begun Phase 1 and lacks sufficient evidence of efficacy."
Are there any available slots for enrollees in this research program?
"Clinicaltrials.gov reveals that this research endeavour is actively recruiting participants, with the initial posting having been made on June 3rd 2022 and subsequent updates issued on August 11th of the same year."
Can I be selected to partake in this experiment?
"To meet the criteria of this clinical trial, applicants must be ages 18 to 50 and have been diagnosed with COVID-19. The trial is currently accepting 36 participants in total."
How many participants is the maximum capacity of this research endeavor?
"This trial requires 36 qualified patients located in various regions. Two of the participating sites are Icahn School of Medicine at Mt. Sinai, New york and Ark Clinical Research, Long Beach, California."
To what extent are hospitals participating in this experiment?
"Currently, individuals can sign up for this trial at 4 different locations: New york City, Long Beach, and Miami Lakes are a few of the sites. Choosing to take part at the closest medical centre helps limit your travel burden."
Share this study with friends
Copy Link
Messenger